RecruitingNot ApplicableNCT07285356

Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy

GLOX-PEN: Phase II Clinical Trial to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy


Sponsor

AC Camargo Cancer Center

Enrollment

84 participants

Start Date

Oct 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether wearing surgical gloves during chemotherapy infusions can prevent nerve damage in the hands and feet — a painful and common side effect called peripheral neuropathy — in people receiving oxaliplatin chemotherapy for colon cancer. **You may be eligible if...** - You are 18 or older with colon cancer (high-risk stage III or stage IV) - You are being treated with oxaliplatin-based chemotherapy (either for localized or metastatic disease) - Your functional status is good (ECOG 0–1, meaning you can carry out daily activities independently) - You have provided written informed consent **You may NOT be eligible if...** - You already have nerve damage in your hands or feet (pre-existing neuropathy) - You have uncontrolled diabetes, which can also cause nerve problems - You have a known allergy to surgical gloves - You have previously been treated with paclitaxel, docetaxel, or oxaliplatin chemotherapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESurgical Gloves

During each chemotherapy cycle, patients in the experimental group will wear compressive surgical gloves (one size smaller than recommended based on palmar surface measurement) on both hands, which will be put on 30 minutes before the infusion and remain in place until 30 minutes after the end of the chemotherapy infusion.


Locations(1)

A.C. Camargo Cancer Center

São Paulo, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07285356


Related Trials